179 related articles for article (PubMed ID: 23699837)
1. Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.gov.
Hirsch BR; Califf RM; Cheng SK; Tasneem A; Horton J; Chiswell K; Schulman KA; Dilts DM; Abernethy AP
JAMA Intern Med; 2013 Jun; 173(11):972-9. PubMed ID: 23699837
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
Califf RM; Zarin DA; Kramer JM; Sherman RE; Aberle LH; Tasneem A
JAMA; 2012 May; 307(17):1838-47. PubMed ID: 22550198
[TBL] [Abstract][Full Text] [Related]
3. Clinical research in surgical oncology: an analysis of ClinicalTrials.gov.
Menezes AS; Barnes A; Scheer AS; Martel G; Moloo H; Boushey RP; Sabri E; Auer RC
Ann Surg Oncol; 2013 Nov; 20(12):3725-31. PubMed ID: 23800894
[TBL] [Abstract][Full Text] [Related]
4. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
5. Sponsorship and design characteristics of trials registered in ClinicalTrials.gov.
Roumiantseva D; Carini S; Sim I; Wagner TH
Contemp Clin Trials; 2013 Mar; 34(2):348-55. PubMed ID: 23380028
[TBL] [Abstract][Full Text] [Related]
6. The Landscape of Clinical Trials Evaluating the Theranostic Role of PET Imaging in Oncology: Insights from an Analysis of ClinicalTrials.gov Database.
Chen YP; Lv JW; Liu X; Zhang Y; Guo Y; Lin AH; Sun Y; Mao YP; Ma J
Theranostics; 2017; 7(2):390-399. PubMed ID: 28042342
[TBL] [Abstract][Full Text] [Related]
7. Overview of registered studies in orthodontics: Evaluation of the ClinicalTrials.gov registry.
Allareddy V; Rampa S; Masoud MI; Lee MK; Nalliah R; Allareddy V
Am J Orthod Dentofacial Orthop; 2014 Nov; 146(5):587-93. PubMed ID: 25439209
[TBL] [Abstract][Full Text] [Related]
8. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
[TBL] [Abstract][Full Text] [Related]
9. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.
Dilts DM; Sandler AB
J Clin Oncol; 2006 Oct; 24(28):4545-52. PubMed ID: 17008693
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials in cancer. Part I. Biomedical, complementary, and alternative medicine: finding active trials and results of closed trials.
Lee CO
Clin J Oncol Nurs; 2004 Oct; 8(5):531-5. PubMed ID: 15515286
[TBL] [Abstract][Full Text] [Related]
11. Visions of hope in cancer: focus on infrastructure: comment on "characteristics of oncology clinical trials" and "toward accountable cancer care".
Bach PB
JAMA Intern Med; 2013 Jun; 173(11):979-80. PubMed ID: 23700172
[No Abstract] [Full Text] [Related]
12. Using ClinicalTrials.gov to understand the state of clinical research in pulmonary, critical care, and sleep medicine.
Todd JL; White KR; Chiswell K; Tasneem A; Palmer SM
Ann Am Thorac Soc; 2013 Oct; 10(5):411-7. PubMed ID: 23987571
[TBL] [Abstract][Full Text] [Related]
13. Phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties.
Michaelis LC; Ratain MJ
Clin Cancer Res; 2007 Apr; 13(8):2400-5. PubMed ID: 17438099
[TBL] [Abstract][Full Text] [Related]
14. The clinical development of molecularly targeted agents in combination with radiation therapy: a pharmaceutical perspective.
Ataman OU; Sambrook SJ; Wilks C; Lloyd A; Taylor AE; Wedge SR
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e447-54. PubMed ID: 22819210
[TBL] [Abstract][Full Text] [Related]
15. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology.
Riechelmann RP; Wang L; O'Carroll A; Krzyzanowska MK
J Clin Oncol; 2007 Oct; 25(29):4642-7. PubMed ID: 17925561
[TBL] [Abstract][Full Text] [Related]
16. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of patient-reported outcomes in cancer clinical trials.
Gotay CC; Kawamoto CT; Bottomley A; Efficace F
J Clin Oncol; 2008 Mar; 26(8):1355-63. PubMed ID: 18227528
[TBL] [Abstract][Full Text] [Related]
18. Surgeons: A Future Role in Clinical Trials?
Rusch VW
Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050
[TBL] [Abstract][Full Text] [Related]
19. The database for aggregate analysis of ClinicalTrials.gov (AACT) and subsequent regrouping by clinical specialty.
Tasneem A; Aberle L; Ananth H; Chakraborty S; Chiswell K; McCourt BJ; Pietrobon R
PLoS One; 2012; 7(3):e33677. PubMed ID: 22438982
[TBL] [Abstract][Full Text] [Related]
20. [Clinical research in Germany at the example of oncology].
Seufferlein T; Adler G
Onkologie; 2010; 33 Suppl 7():1-5. PubMed ID: 20926906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
